HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takuro Kanekura Selected Research

Blood Component Removal (Apheresis)

4/2022Granulocyte and monocyte adsorptive apheresis for pyoderma gangrenosum.
12/2021The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.
8/2021Successful treatment of pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome with granulocyte and monocyte adsorption apheresis.
10/2020Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19.
11/2018Successful treatment of plaque-type psoriasis by granulocyte and monocyte adsorption apheresis in a patient with psoriatic arthritis.
8/2018Clinical and immunological effects of adsorptive myeloid lineage leukocyte apheresis in patients with immune disorders.
6/2018Granulocyte and monocyte adsorption apheresis for palmoplantar pustulosis with extra-palmoplantar lesions and pustulotic arthro-osteitis.
1/2018Genetic background and therapeutic response in generalized pustular psoriasis patients treated with granulocyte and monocyte adsorption apheresis.
12/2017Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics.
10/2013Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takuro Kanekura Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 06/2002
15Melanoma (Melanoma, Malignant)
01/2022 - 06/2002
10Neoplasm Metastasis (Metastasis)
12/2019 - 06/2002
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2019 - 11/2007
7Psoriasis (Pustulosis Palmaris et Plantaris)
12/2021 - 08/2003
6Skin Diseases (Skin Disease)
04/2022 - 08/2003
5Pyoderma Gangrenosum
04/2022 - 08/2002
5Dermatitis
12/2021 - 01/2003
5Carcinogenesis
11/2020 - 02/2005
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2019 - 02/2006
5Bullous Pemphigoid (Pemphigoid)
12/2017 - 10/2012
4Systemic Scleroderma (Systemic Sclerosis)
11/2020 - 07/2012
4Hypersensitivity (Allergy)
02/2020 - 11/2009
4Psoriatic Arthritis
11/2018 - 02/2004
4Inflammation (Inflammations)
01/2018 - 01/2006
4Fabry Disease (Fabry's Disease)
04/2012 - 11/2009
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2021 - 07/2019
3Extramammary Paget Disease (Paget Disease, Extramammary)
07/2013 - 08/2005
3Carcinoma (Carcinomatosis)
05/2010 - 08/2005
2Burns
01/2021 - 01/2014
2Eosinophilia
02/2020 - 11/2019
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2020 - 10/2012
2Lymphadenopathy
11/2019 - 01/2012
2Bowen's Disease (Disease, Bowen)
11/2018 - 11/2007
2Keratoacanthoma
02/2017 - 11/2007
2Pemphigus (Pemphigus Vulgaris)
07/2016 - 04/2013
2Erythema elevatum diutinum
11/2014 - 06/2010
2Erythropoietic Protoporphyria
03/2014 - 09/2006
2Erythema Nodosum
09/2013 - 01/2004
2Kimura Disease
09/2013 - 01/2004
2Hypoxia (Hypoxemia)
03/2013 - 06/2010
2Skin Neoplasms (Skin Cancer)
10/2012 - 07/2004
2Rheumatoid Arthritis
05/2012 - 06/2005
2Seborrheic Keratosis
01/2011 - 11/2007
2Ulcer
08/2005 - 05/2005
2Type I Schindler Disease
03/2005 - 01/2005
1Skin Ulcer
04/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Collagen Diseases (Collagen Disease)
12/2021
1Hidradenitis Suppurativa
08/2021
1Acne Vulgaris
08/2021

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2009
7EnzymesIBA
04/2012 - 03/2005
6Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
12/2021 - 06/2002
6Small Interfering RNA (siRNA)IBA
10/2021 - 12/2006
6Matrix Metalloproteinases (MMPs)IBA
12/2014 - 06/2002
5Monoclonal AntibodiesIBA
12/2019 - 02/2005
5AntibodiesIBA
12/2017 - 04/2013
4Pharmaceutical PreparationsIBA
02/2020 - 01/2006
4DNA (Deoxyribonucleic Acid)IBA
11/2018 - 04/2003
4AntigensIBA
01/2018 - 03/2008
4Immunoglobulin G (IgG)IBA
04/2017 - 03/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 12/2006
3Immune Checkpoint InhibitorsIBA
01/2022 - 02/2020
3LectinsIBA
01/2022 - 03/2007
3Immunoglobulins (Immunoglobulin)IBA
12/2021 - 07/2012
3Imiquimod (Aldara)FDA LinkGeneric
12/2021 - 01/2018
3CytokinesIBA
10/2020 - 01/2014
3Cadherins (E-Cadherin)IBA
07/2019 - 11/2007
3GlycosphingolipidsIBA
01/2013 - 03/2005
2AsparagineIBA
01/2022 - 10/2020
2pembrolizumabIBA
01/2022 - 12/2019
2Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2010
2Histone Deacetylase InhibitorsIBA
10/2021 - 03/2021
2Ointments (Pastes)IBA
01/2021 - 02/2009
2Transcription Factors (Transcription Factor)IBA
11/2020 - 01/2013
2CollagenIBA
11/2020 - 02/2005
2EtretinateFDA Link
07/2019 - 02/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 06/2010
2Polysaccharides (Glycans)IBA
01/2019 - 02/2012
2Mannose (D-Mannose)IBA
01/2019 - 03/2007
2AllergensIBA
11/2018 - 05/2005
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2011
2AutoantibodiesIBA
07/2016 - 05/2012
2Heme (Haem)IBA
03/2014 - 09/2006
2Peptide Hydrolases (Proteases)FDA Link
01/2014 - 08/2008
2NicotineFDA Link
09/2013 - 01/2004
2RNA (Ribonucleic Acid)IBA
10/2012 - 12/2006
2Glycoproteins (Glycoprotein)IBA
02/2012 - 11/2008
2globotriaosylceramide (globotriosylceramide)IBA
09/2010 - 11/2009
2Lactic Acid (Lactate)FDA LinkGeneric
03/2010 - 01/2009
2alpha-N-Acetylgalactosaminidase (N-Acetyl-alpha-D-Galactosaminidase)IBA
11/2009 - 01/2005
2Estrogens (Estrogen)FDA Link
01/2006 - 01/2003
1IntegrinsIBA
01/2022
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022
1NivolumabIBA
01/2022
1QuercetinIBA
10/2021
1VorinostatFDA Link
10/2021
1InterferonsIBA
04/2021
1Propolis (Bee Bread)IBA
01/2021
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
11/2020
1LigandsIBA
11/2020
1Deoxyglucose (2 Deoxy D glucose)IBA
10/2020

Therapy/Procedure

19Blood Component Removal (Apheresis)
04/2022 - 08/2002
12Therapeutics
04/2022 - 08/2003
4Drug Therapy (Chemotherapy)
11/2019 - 08/2005
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2012 - 07/2003
3Enzyme Replacement Therapy
02/2012 - 11/2009
2Combination Drug Therapy (Combination Chemotherapy)
10/2011 - 08/2005
1Immunotherapy
01/2022